Vaccination by non-parenteral routes: characteristics of immune response
- PMID: 782968
Vaccination by non-parenteral routes: characteristics of immune response
Abstract
Antibody and cell-mediated immune response in systemic and external mucosal sites was studied after natural or vaccine induced infections with rubella and mumps viruses. Natural rubella infection or immunization with RA27/3 rubella vaccine by intranasal and frequently by the subcutaneous route resulted in regular appearance of antibody response in the serum and respiratory tract and cellular immunity in circulating lymphocytes and tonsillar lymphoid tissue. Subcutaneous immunization with HPV-77 and Cendehill rubella vaccine resulted in antibody response in the serum with little or no response in the respiratory tract. A minimal cell-mediated immune response in systemic or respiratory lymphoid tissue was observed after such immunization. Intranasal immunization with HPV-77 frequently elicited a transient antibody and cell-mediated activity in the respiratory tract with no response in the serum and peripheral lymphocytes. Studies carried out with natural mumps infection or subcutaneous immunization with live attenuated mumps vaccine suggested that either route of infection may result in the development of antibody and cell-mediated immune responses in systemic sites as well as in the respiratory tract. These observations suggest that the immunologic outcome of immunization by non-parenteral route may be determined by the types of viral antigen employed, the nature of locally available immuno-competent tissue, the ability of mucosal site to capture an antigen or accept replication of live virus vaccines, and the degree of prior sensitization with the same antigen.
Similar articles
-
Immunologic and virologic aspects of secretory immune system in human respiratory tract.Dev Biol Stand. 1975;28:129-44. Dev Biol Stand. 1975. PMID: 47823
-
Cell-mediated immune response to mumps virus infection in man.J Immunol. 1976 Jan;116(1):12-5. J Immunol. 1976. PMID: 1245735
-
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. Schweiz Med Wochenschr. 1998. PMID: 9622837 German.
-
Mucosal responses to parenteral and mucosal vaccines.Dev Biol Stand. 1998;95:141-6. Dev Biol Stand. 1998. PMID: 9855424 Review.
-
[Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].Ugeskr Laeger. 1992 Jul 13;154(29):2008-13. Ugeskr Laeger. 1992. PMID: 1509566 Review. Danish.
Cited by
-
Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.J Exp Med. 1993 Oct 1;178(4):1309-20. doi: 10.1084/jem.178.4.1309. J Exp Med. 1993. PMID: 8376936 Free PMC article.
-
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2201616119. doi: 10.1073/pnas.2201616119. Epub 2022 Jul 27. Proc Natl Acad Sci U S A. 2022. PMID: 35895717 Free PMC article.
-
The common mucosal immune system and current strategies for induction of immune responses in external secretions.J Clin Immunol. 1987 Jul;7(4):265-76. doi: 10.1007/BF00915547. J Clin Immunol. 1987. PMID: 3301884 Review.
-
Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.Infect Immun. 1999 Nov;67(11):5841-7. doi: 10.1128/IAI.67.11.5841-5847.1999. Infect Immun. 1999. PMID: 10531238 Free PMC article.
-
Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.Infect Immun. 1992 Feb;60(2):465-71. doi: 10.1128/iai.60.2.465-471.1992. Infect Immun. 1992. PMID: 1730477 Free PMC article.